Skip to search formSkip to main contentSkip to account menu

tenofovir alafenamide

Known as: TAF, bis{9-[(2R,5S,7E)-2,7,10-trimethyl-5,8-dioxo-5-phenoxy-3,9-dioxa-6-aza-5?5-phosphaundecan-1-yl]-9H-purin-6-aminium} (2E)-but-2-enedioate, bis{propan-2-yl N-[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl]-L-alaninate} (2E)-but-2-enedioate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Abstract: In 2 double-blind phase 3 trials, 1733 antiretroviral-naive adults were randomized to tenofovir alafenamide (TAF) or… 
Highly Cited
2015
Highly Cited
2015
ABSTRACT Tenofovir alafenamide (TAF) is a prodrug of tenofovir (TFV) currently in clinical evaluation for treatment for HIV and… 
Highly Cited
2007
Highly Cited
2007
This paper presents a new classifier called total margin-based adaptive fuzzy support vector machines (TAF-SVM) that deals with… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT The general transcription factor TFIID is a multisubunit complex of TATA-binding protein (TBP) and 14 distinct TBP… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT River microbial communities play an important role in global nutrient cycles, and aggregated bacteria such as those in… 
Highly Cited
1994
Highly Cited
1994
In Drosophila and human cells, the TATA binding protein (TBP) of the transcription factor IID (TFIID) complex is tightly…